• About Us
  • Our Editorial Policy
  • Business Directory
  • Advertise with Us
  • Our Advertisers
  • Contact Us
Australia India News
  • Alluring India - Brisbane Banner
India News Australia
  • Home
  • Current Issue
    Past Issue
  • India News
  • Business
  • World
    World This Week
  • Community News
  • What's On
  • Others
    Yoga in Australia News COVID-19 Community News Naari IPL News Health Travel Entertainment
  • National Events
  • Alluring India 2026
  • Please wait..
India News News

Delhi HC issues contempt notice to CDSCO over delay in acting on diabetes drugs used for weight management

  • BY India News Newsdesk
  • March 17, 2026
  • 0 COMMENTS

New Delhi, March 17 (IANS) The Delhi High Court, on Tuesday, issued notice on a contempt petition alleging non-compliance with its earlier order directing Central Drugs Standard Control Organisation (CDSCO) to examine safety and regulatory concerns regarding the use of certain diabetes drugs for weight loss.

A single-judge bench of Justice Sachin Datta sought responses from the Drugs Controller General of India (DCGI) and the Union Health Secretary Punya Salila Srivastava, and granted them four weeks to file their replies.

The matter has been listed for further hearing on May 21.

The contempt plea, filed through advocate Rohit Kumar, alleged that the authorities failed to comply with the Delhi High Court’s July 2025 direction requiring them to decide on a representation raising regulatory concerns about the use of GLP-1 receptor agonist drugs for weight management and aesthetic treatment.

According to the petition, a bench of Chief Justice Devendra Upadhyaya and Justice Tushar Rao Gedela had earlier permitted the petitioner to submit a supplementary representation along with relevant material and directed the competent authority to consider the same in accordance with law, consult experts and stakeholders, including manufacturers, and take a decision within three months of its submission.

Appearing for the petitioner, the counsel submitted that despite clear judicial directions, “no substantive steps” were taken for several months.

It was said that although a supplementary representation had been filed on July 13, 2025, the authorities failed to act on it within the prescribed three-month period.

The representation, the contempt plea said, highlighted issues, including waiver of India-specific clinical trials, under the New Drugs and Clinical Trials Rules, 2019, alleged gaps in pharmacovigilance safeguards, regulatory inconsistencies, and aggressive marketing practices.

It also added that even after reminders, including an email sent on January 29, 2026, no response was received from the authorities.

Saying that nearly eight months had passed since submission of the representation, the petitioner contended that the continued inaction amounts to wilful disobedience of the Delhi High Court’s binding directions.

The petition said that the order passed on July 2, 2025, imposed a “clear and time-bound obligation” on CDSCO to take a decision within three months, and that “mere internal processing or informal emails saying that the matter is under consideration do not constitute compliance with a binding judicial direction”.

–IANS

pds/khz

Post navigation

Missing man’s body found in waterfall in MP’s Mauganj
Indian Army, NDRF conduct joint flood relief training exercise ‘Jal Raksha’ in Assam

Related Post

Jodhpur C-section complications: Use of 25 medicines suspended, AIIMS to probe
June 23, 2026
Raj CM in Delhi today to attend a high-level meeting on Yamuna Water Project for Shekhawati region
June 23, 2026
Coast Guard’s fast patrol vessel ‘Achal’ to further strengthen maritime security
June 23, 2026
Tamil Nadu plans sharp increase in fees for fancy vehicle registration numbers
June 23, 2026

Our Current Issue

Alluring India 2026

Alluring India 2026

Our Advertisers

  • Battery Rebate australia
  • Bess Australia Solar Panels
  • Alluring India - Brisbane 2026

Follow Us

  • facebook
  • facebook
  • facebook
  • facebook
INDIA NEWS on YouTube in Australia, bring to our readers and subscribers national and international news, editorials, expert columns, community activities and interviews of political leaders, celebrities, business professionals, academics and sport personalities among others.
  • facebook
  • facebook
  • facebook
  • facebook

Category

  • Accident
  • Adani Australia
  • Advertorial
  • Arts & Culture
  • Ashes 2022
  • Australia

Recent News

  • Oracle cuts 21,000 jobs in a year,...
  • Jodhpur C-section complications: Use of 25 medicines...

Subscribe Newsletter

Get the latest creative news from india news

  • Privacy Policy
  • Disclaimer
Alluring India 2026